These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33839011)

  • 1. Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery.
    Walsh MM; Khan R; Kwaan HC; Neal MD
    J Am Coll Surg; 2021 Jun; 232(6):1003-1006. PubMed ID: 33839011
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19-associated Coagulopathy.
    Görlinger K; Levy JH
    Anesthesiology; 2021 Mar; 134(3):366-369. PubMed ID: 33417671
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
    Nielsen ND; Rollins-Raval MA; Raval JS; Thachil J
    Thromb Res; 2022 Feb; 210():1-3. PubMed ID: 34953317
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.
    Weiss E; Roux O; Moyer JD; Paugam-Burtz C; Boudaoud L; Ajzenberg N; Faille D; de Raucourt E
    Thromb Haemost; 2020 Sep; 120(9):1343-1345. PubMed ID: 32645725
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis Shutdown in Severe COVID-19: Highly Prevalent but not Independently Predictive of Thrombosis or Poorer Outcomes.
    Littlejohn J; Vasovic LV; Cushing MM; Barie PS
    J Am Coll Surg; 2022 Jan; 234(1):97-98. PubMed ID: 35213468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dealing with COVID-19-associated coagulopathy].
    Klok FA; den Exter PL; Huisman MV; Eikenboom J
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.
    Meizoso JP; Moore HB; Moore EE
    J Am Coll Surg; 2021 Jun; 232(6):995-1003. PubMed ID: 33766727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.
    Salabei JK; Fishman TJ; Asnake ZT; Ali A; Iyer UG
    Heart Lung; 2021; 50(2):357-360. PubMed ID: 33524866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
    Magro G
    Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
    [No Abstract]   [Full Text] [Related]  

  • 11. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
    Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
    Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
    Zhang X; Yang X; Jiao H; Liu X
    Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease 2019-Associated Coagulopathy.
    Lippi G; Sanchis-Gomar F; Favaloro EJ; Lavie CJ; Henry BM
    Mayo Clin Proc; 2021 Jan; 96(1):203-217. PubMed ID: 33413819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on coronavirus disease 2019 associated coagulopathy.
    Yang XH; Li RR; Sun RH; Liu J; Chen DC
    Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Levi M; Iba T
    Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
    Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
    Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated coagulopathy.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy associated with COVID-19.
    Bílková S; Hirmerová J
    Vnitr Lek; 2020; 66(7):402-408. PubMed ID: 33380117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
    Creel-Bulos C; Sniecinski R
    Shock; 2021 Jun; 55(6):845-846. PubMed ID: 33989265
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolysis Shutdown in COVID-19-Infected Patients Can Result from Iron-Induced Stabilization of Fibril Clots.
    Sukhomlin T
    J Am Coll Surg; 2020 Nov; 231(5):607-608. PubMed ID: 32972832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.